Report Detail

Pharma & Healthcare Global Clinical Mass Spectrometry Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2940100
  • |
  • 14 February, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics.

Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

Scope of the Report:
The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, the Asia has little production, it only occupies about 10% market share in 2015. The largest company is Thermo Fisher, it occupies more than 26% of the market share, and the second largest company is AB Sciex (Danaher).
The largest consumption region is North America, it occupies about 46% market share in 2015, the second largest region is the Europe, it occupies about 32% market share, and the smallest consumption region is ROW, the consumption rate in China is about 6% in 2015.
In the last five years, the Clinical Mass Spectrometry has great consumption growth rate, it can be divided into two types LC-MS and GC-MS, the LC-MS occupies about 81% market share in 2015, in the application region, it mainly used in the Clinical Research, it occupies about 74% market share in 2015; In the future, the permeability will have high growth rate, the price have great relationship with the raw material and technology.
The worldwide market for Clinical Mass Spectrometry is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 920 million US$ in 2024, from 640 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Clinical Mass Spectrometry in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Thermo Fisher
AB Sciex (Danaher)
Waters
Agilent
Bruker
Perkin Elmer
Shidmazu

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
LC-MS
GC-MS

Market Segment by Applications, can be divided into
Clinical Diagnostics
Clinical Research

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Clinical Mass Spectrometry product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Clinical Mass Spectrometry, with price, sales, revenue and global market share of Clinical Mass Spectrometry in 2017 and 2018.
Chapter 3, the Clinical Mass Spectrometry competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Clinical Mass Spectrometry breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Clinical Mass Spectrometry market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Clinical Mass Spectrometry sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Clinical Mass Spectrometry Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 LC-MS
      • 1.2.2 GC-MS
    • 1.3 Market Analysis by Applications
      • 1.3.1 Clinical Diagnostics
      • 1.3.2 Clinical Research
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Thermo Fisher
      • 2.1.1 Business Overview
      • 2.1.2 Clinical Mass Spectrometry Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Thermo Fisher Clinical Mass Spectrometry Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 AB Sciex (Danaher)
      • 2.2.1 Business Overview
      • 2.2.2 Clinical Mass Spectrometry Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 AB Sciex (Danaher) Clinical Mass Spectrometry Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Waters
      • 2.3.1 Business Overview
      • 2.3.2 Clinical Mass Spectrometry Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Waters Clinical Mass Spectrometry Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Agilent
      • 2.4.1 Business Overview
      • 2.4.2 Clinical Mass Spectrometry Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Agilent Clinical Mass Spectrometry Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Bruker
      • 2.5.1 Business Overview
      • 2.5.2 Clinical Mass Spectrometry Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Bruker Clinical Mass Spectrometry Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Perkin Elmer
      • 2.6.1 Business Overview
      • 2.6.2 Clinical Mass Spectrometry Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Perkin Elmer Clinical Mass Spectrometry Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Shidmazu
      • 2.7.1 Business Overview
      • 2.7.2 Clinical Mass Spectrometry Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Shidmazu Clinical Mass Spectrometry Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Clinical Mass Spectrometry Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Clinical Mass Spectrometry Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Clinical Mass Spectrometry Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Clinical Mass Spectrometry Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Clinical Mass Spectrometry Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Clinical Mass Spectrometry Market Analysis by Regions

    • 4.1 Global Clinical Mass Spectrometry Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Clinical Mass Spectrometry Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Clinical Mass Spectrometry Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 4.3 Europe Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 4.5 South America Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)

    5 North America Clinical Mass Spectrometry by Country

    • 5.1 North America Clinical Mass Spectrometry Sales, Revenue and Market Share by Country
      • 5.1.1 North America Clinical Mass Spectrometry Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Clinical Mass Spectrometry Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 5.3 Canada Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)

    6 Europe Clinical Mass Spectrometry by Country

    • 6.1 Europe Clinical Mass Spectrometry Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Clinical Mass Spectrometry Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Clinical Mass Spectrometry Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 6.3 UK Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 6.4 France Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 6.5 Russia Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 6.6 Italy Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Clinical Mass Spectrometry by Country

    • 7.1 Asia-Pacific Clinical Mass Spectrometry Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Clinical Mass Spectrometry Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Clinical Mass Spectrometry Revenue and Market Share by Country (2014-2019)
    • 7.2 China Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 7.3 Japan Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 7.4 Korea Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 7.5 India Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)

    8 South America Clinical Mass Spectrometry by Country

    • 8.1 South America Clinical Mass Spectrometry Sales, Revenue and Market Share by Country
      • 8.1.1 South America Clinical Mass Spectrometry Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Clinical Mass Spectrometry Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Clinical Mass Spectrometry by Countries

    • 9.1 Middle East and Africa Clinical Mass Spectrometry Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Clinical Mass Spectrometry Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Clinical Mass Spectrometry Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Clinical Mass Spectrometry Sales and Growth Rate (2014-2019)

    10 Global Clinical Mass Spectrometry Market Segment by Type

    • 10.1 Global Clinical Mass Spectrometry Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Clinical Mass Spectrometry Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Clinical Mass Spectrometry Revenue and Market Share by Type (2014-2019)
    • 10.2 LC-MS Sales Growth and Price
      • 10.2.1 Global LC-MS Sales Growth (2014-2019)
      • 10.2.2 Global LC-MS Price (2014-2019)
    • 10.3 GC-MS Sales Growth and Price
      • 10.3.1 Global GC-MS Sales Growth (2014-2019)
      • 10.3.2 Global GC-MS Price (2014-2019)

    11 Global Clinical Mass Spectrometry Market Segment by Application

    • 11.1 Global Clinical Mass Spectrometry Sales Market Share by Application (2014-2019)
    • 11.2 Clinical Diagnostics Sales Growth (2014-2019)
    • 11.3 Clinical Research Sales Growth (2014-2019)

    12 Clinical Mass Spectrometry Market Forecast (2019-2024)

    • 12.1 Global Clinical Mass Spectrometry Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Clinical Mass Spectrometry Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Clinical Mass Spectrometry Market Forecast (2019-2024)
      • 12.2.2 Europe Clinical Mass Spectrometry Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Clinical Mass Spectrometry Market Forecast (2019-2024)
      • 12.2.4 South America Clinical Mass Spectrometry Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Clinical Mass Spectrometry Market Forecast (2019-2024)
    • 12.3 Clinical Mass Spectrometry Market Forecast by Type (2019-2024)
      • 12.3.1 Global Clinical Mass Spectrometry Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Clinical Mass Spectrometry Market Share Forecast by Type (2019-2024)
    • 12.4 Clinical Mass Spectrometry Market Forecast by Application (2019-2024)
      • 12.4.1 Global Clinical Mass Spectrometry Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Clinical Mass Spectrometry Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Clinical Mass Spectrometry . Industry analysis & Market Report on Clinical Mass Spectrometry is a syndicated market report, published as Global Clinical Mass Spectrometry Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Clinical Mass Spectrometry market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,794.44
      4,191.66
      5,588.88
      3,264.24
      4,896.36
      6,528.48
      537,416.40
      806,124.60
      1,074,832.80
      291,067.20
      436,600.80
      582,134.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report